Karl-Heinz Krause, MD, obtained his medical degree from Ludwig-Maximilian University in Munich, Germany. Following clinical and research training in Munich, Geneva (Switzerland), and Iowa City (USA), he joined the Division of Infectious Diseases at Geneva University Hospitals as a junior faculty member. He was promoted to Associate Professor in 1998 and Full Professor at the University of Geneva Faculty of Medicine in 2001. Since 2024, he is serving as President of the Geneva Foundation for Medical Research. Professor Krause has published extensively in leading international journals, and his work is widely cited. He holds numerous patents and is a founding member of several biotechnology companies. He has served as a scientific advisor to the Swiss National Science Foundation and is an elected member of both the Swiss Academy of Medical Sciences and the American Society for Clinical Investigation. His current research focuses on gene and cell therapy, with a particular emphasis on gene therapy vectors and ocular gene therapy.